「免疫組織化学検査を用いて子宮体癌の予後因子を再検討する」の関連論文
-
膀胱癌におけるエストロゲンレセプターβとシスプラチン耐性獲得機序についての研究
-
胃癌におけるSWI/SNF複合体異常及び免疫回避機構関連因子の検討
-
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling
-
胃癌におけるCD44 variant 9の発現は、細胞内活性酸素種の蓄積を制御し、化学療法抵抗性を誘導する
-
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection
-
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas
-
EGFR-TKI耐性と腫瘍内組織免疫微小環境との相互作用についての検討
-
低腫瘍量濾胞性リンパ腫における遺伝子発現に基づく新規予後予測モデルの構築
-
Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
-
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
-
Study on the clinical outcome and molecular changes of precursor-targeted immune-mediated anemia treated with splenectomy [an abstract of entire text]
-
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies
-
Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
-
口腔白板症におけるp62発現と臨床病理的因子の解析
-
大腸癌における抗癌剤によるカルレティクリン誘導機序の解明
-
初発・再発膠芽腫組織を使用した腫瘍微小環境の変化の解析とテモゾロミド耐性TS細胞に対する抗PD-L1抗体+M2マクロファージ阻害剤併用療法の検討
-
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells
-
Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
-
頭頸部扁平上皮癌における遺伝子変異と蛋白表現型によるp53機能分類
-
膵癌の薬剤抵抗性におけるKEAP1-Nrf2経路の意義に関する検討
-
CEAを標的抗原とするキメラ抗原受容体T細胞による膵臓癌への抗腫瘍効果の研究
-
AFP産生胃癌の治療標的探索と腫瘍免疫回避機構
-
Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer
-
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
-
トリプルネガティブ乳癌におけるグルココルチコイド作用の臨床病理学的意義;アンドロゲンシグナルとの相互作用
-
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: A prospective study
-
PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer
-
膵癌における腹腔洗浄液を用いたリキッドバイオプシーの臨床的有用性の検討
-
肺腺癌における転写因子ASCL1の機能解析
-
Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma
-
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
-
Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis
-
子宮頸部腫瘍病変における形質細胞の臨床的意義に関する研究
-
Expression of hemoglobin beta is associated with poor prognosis and aggressive phenotypes in clear cell renal cell carcinoma
-
大腸癌におけるバンド3異所性発現は赤血球膜結合IgGの増加を誘発し、免疫関連貧血の原因となる可能性がある
-
High RAD18 expression is associated with disease progression and poor prognosis in patients with gastric cancer
-
Clinical significance of serglycin expression in human breast cancer patients
-
ホルモン受容体陽性・HER2陽性乳癌の腫瘍内不均質性に関する検討
-
A multicenter, open‑label, single‑arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
-
The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
-
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors
-
非小細胞肺がん患者におけるオシメルチニブ有害事象とSTAT3, CYP3A5, ABCG2遺伝子多型との関連
-
術前化学療法を施行した食道扁平上皮癌におけるGlucocorticoid(GC)-Glucocorticoid receptor(GR)伝達経路関連因子の臨床病理学的,免疫組織学的検討
-
抗がん分子標的抗体療法に向けての基礎研究
-
Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer
-
肝細胞癌に対するレンバニチブ療法の臨床効果に及ぼすNOS3遺伝子多型の影響
-
転移・浸潤に関わるタンパク質Rho, ROCKの発現と、同時化学放射線療法後の子宮頸癌の予後との関係について
-
膵神経内分泌腫瘍におけるクロマチンリモデリング因子異常と腫瘍進展・予後との関連